Alpha Tau Medical (DRTS) Cash & Current Investments (2020 - 2026)

Alpha Tau Medical has disclosed Cash & Current Investments across 7 years of filings, most recently posting $76.4 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $76.4 million, up 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.4 million (up 48.0% YoY), and the FY2025 annual result was $73.1 million, up 22.69% from the prior year.
• Cash & Current Investments came in at $76.4 million for Q1 2026 at Alpha Tau Medical, up from $73.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $8.2 billion in Q1 2022 to a low of $51.6 million in Q1 2025.
• The 5-year median for Cash & Current Investments is $79.7 million (2025), against an average of $559.1 million.
• Across the five-year window, Cash & Current Investments surged 68881.88% in 2022 and slumped 98.78% in 2023, its largest moves.
• Alpha Tau Medical's Cash & Current Investments stood at $104.5 million in 2022, then dropped by 21.76% to $81.8 million in 2023, then dropped by 27.13% to $59.6 million in 2024, then rose by 22.69% to $73.1 million in 2025, then grew by 4.5% to $76.4 million in 2026.
• The last three Cash & Current Investments figures came in at $76.4 million (Q1 2026), $73.1 million (Q4 2025), and $72.2 million (Q3 2025), per Business Quant data.